TIP Regimen in Germ Cell Tumors: Long-Term Outcomes

Yüksel Ürün shared on X:

“TIP Regimen in Germ Cell Tumors: Long-Term Outcomes

• Paclitaxel, Ifosfamide, Cisplatin (TIP) is a proven salvage therapy for GCT.
  
• 104 patients: 87 favorable risk, 17 unfavorable risk. 5-year PFS: 66%, OS: 69%.
  
• Effective for both favorable and unfavorable risks.
  
• Awaiting TIGER trial results for optimal 2nd-line therapy.

‘Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease‘

Authors:  Jack P. Gleeson, Andrea Knezevic, Maria Bromberg, Sujata Patil, Joel Sheinfeld, Brett S. Carver, Manjit Bains, David R. Jones, Dean F. Bajorin, George J. Bosl, Deaglan J. McHugh, Samuel A. Funt, Robert J. Motzer, and Darren R. Feldman.”

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.